Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita
article
OA: gold
CC0
⤵ 2 in-corpus citations
AI-generated summary
Danazol, oxymetholone, and nandrolone similarly enhanced telomerase activity in human hematopoietic cells from dyskeratosis congenita patients in vitro.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
in AD mechanism of action. In conclusion, no significant differences in the ability to functionally enhance telomerase activity could be observed for the three AD studied in vitro. Physicians therefore might choose treatment based on patients' individual co-morbidities, e.g., pre-existing liver disease and expected side-effects.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions via openalex
- Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry via openalex
- Danazol Treatment for Telomere Diseases via openalex
- Haematological recovery in dyskeratosis congenita patients treated with danazol via openalex
- Treatment of the bone marrow failure in Fanconi anemia patients with danazol via openalex
- doi:10.1128/mmbr.66.3.407-425.2002 via openalex
- doi:10.3324/haematol.2011.055269 via openalex
- doi:10.1111/j.2047-2927.2012.00009.x via openalex
- doi:10.1111/nyas.14248 via openalex
- doi:10.1007/s00277-012-1454-x via openalex
- doi:10.1002/ajh.2830500306 via openalex
- doi:10.1182/blood.v97.2.575 via openalex
- doi:10.1016/s0301-472x(02)00888-3 via openalex
- doi:10.1038/nrc3025 via openalex
- doi:10.7554/elife.08687 via openalex
- doi:10.1182/blood-2008-09-178871 via openalex
- doi:10.1056/nejmra0903373 via openalex
- doi:10.1182/bloodadvances.2018017772 via openalex
- doi:10.1182/asheducation-2017.1.96 via openalex
- doi:10.1038/sj.leu.2404339 via openalex
- doi:10.1182/blood.2019003079 via openalex
- doi:10.1038/ncomms5330 via openalex
- doi:10.1182/blood-2019-130844 via openalex
- doi:10.1182/blood-2004-10-3996 via openalex
- doi:10.1182/blood.v34.3.283.283 via openalex
- doi:10.1182/blood.v96.12.3991 via openalex
- doi:10.1097/00002030-200303280-00008 via openalex
- doi:10.1182/blood.v97.4.895 via openalex
- doi:10.1084/jem.190.2.157 via openalex
- doi:10.1073/pnas.91.21.9857 via openalex
- doi:10.1182/blood-2014-05-526285 via openalex
- doi:10.1182/bloodadvances.2018016964 via openalex
- doi:10.1038/nchembio.2007.38 via openalex
- doi:10.3346/jkms.2005.20.3.409 via openalex
- doi:10.1111/bjh.16997 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-13T19:33:11.649412+00:00
License: CC0
· commercial use OK